TMEM167A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.905400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.256400E-01
Normal-vs-Stage2
6.298400E-01
Normal-vs-Stage3
5.346400E-01
Normal-vs-Stage4
2.872000E-01
Stage1-vs-Stage2
4.911200E-01
Stage1-vs-Stage3
1.136410E-01
Stage1-vs-Stage4
5.607800E-01
Stage2-vs-Stage3
1.992360E-01
Stage2-vs-Stage4
1.809410E-01
Stage3-vs-Stage4
1.299050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.843200E-01
Normal-vs-AfricanAmerican
3.699800E-01
Normal-vs-Asian
7.625600E-01
Caucasian-vs-AfricanAmerican
4.037800E-01
Caucasian-vs-Asian
1.372560E-01
AfricanAmerican-vs-Asian
9.078200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.688600E-01
Normal-vs-Female
6.116400E-01
Male-vs-Female
8.509400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.131200E-01
Normal-vs-Age(41-60Yrs)
3.089000E-01
Normal-vs-Age(61-80Yrs)
7.346400E-01
Normal-vs-Age(81-100Yrs)
9.497800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.271400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.183800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.126800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.266490E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.539600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.738800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.913000E-01
Normal-vs-Daily Drinker
7.749800E-01
Normal-vs-Weekly Drinker
9.556400E-01
Normal-vs-Occasional Drinker
3.259200E-01
Normal-vs-Social Drinker
4.768600E-01
Non Drinker-vs-Daily Drinker
2.397600E-01
Non Drinker-vs-Weekly Drinker
5.542800E-01
Non Drinker-vs-Occasional Drinker
1.333650E-02
Non Drinker-vs-Social Drinker
7.584300E-02
Daily Drinker-vs-Weekly Drinker
6.338200E-01
Daily Drinker-vs-Occasional Drinker
1.444970E-01
Daily Drinker-vs-Social Drinker
3.136000E-01
Weekly Drinker-vs-Occasional Drinker
6.818300E-02
Weekly Drinker-vs-Social Drinker
1.755380E-01
Occasional Drinker-vs-Social Drinker
7.820400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.532800E-01
Normal-vs-Grade 2
5.547900E-02
Normal-vs-Grade 3
8.400300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.694000E-01
Grade 1-vs-Grade 3
6.951600E-01
Grade 1-vs-Grade 4
2.532800E-01
Grade 2-vs-Grade 3
6.511600E-01
Grade 2-vs-Grade 4
5.547900E-02
Grade 3-vs-Grade 4
8.400300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.658200E-01
Normal-vs-NonDiabetic
6.567000E-01
Diabetic-vs-NonDiabetic
3.248800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.976000E-01
Normal-vs-NoPancreatitis
6.463800E-01
Pancreatitis-vs-NoPancreatitis
2.834600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.337400E-01
Normal-vs-N1
6.265800E-01
N0-vs-N1
2.691800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.112200E-01
Normal-vs-TP53-NonMutant
5.407600E-01
TP53-Mutant-vs-TP53-NonMutant
8.386200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
